Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ananthakrishnan

Showing results (481-490 of 592) with videos related to

Pageof 60
Sort By:
Alimentary Pharmacology & Therapeutics|April 14, 2015
Diabetes and the risk of infections with immunomodulator therapy in inflammatory bowel diseasesA N Ananthakrishnan, A Cagan, T Cai, et al.
The American Journal of Gastroenterology|October 22, 2025
Comparative Safety of Advanced Therapies in Patients with Ulcerative Colitis: An Administrative Claims-based StudyDhruv Ahuja, Claudia Dziegielewski, Kuan-Hung Yeh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 25, 2016
Statin Use Is Associated With Reduced Risk of Colorectal Cancer in Patients With Inflammatory Bowel DiseasesAshwin N Ananthakrishnan, Andrew Cagan, Tianxi Cai, et al.
The American Journal of Gastroenterology|February 13, 2026
The bidirectional relationship between cognitive function and active inflammatory bowel diseaseBharati Kochar, Adam S Faye, Elizabeth Araka, et al.
Gastroenterology|May 12, 2020
Dietary Inflammatory Potential and Risk of Crohn's Disease and Ulcerative ColitisChun-Han Lo, Paul Lochhead, Hamed Khalili, et al.
Digestive Diseases and Sciences|November 1, 2016
Vedolizumab Therapy Is Associated with an Improvement in Sleep Quality and Mood in Inflammatory Bowel DiseasesBetsy W Stevens, Nynke Z Borren, Gabriella Velonias, et al.
Gastroenterology|November 19, 2023
AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Crohn's DiseaseAshwin N Ananthakrishnan, Jeremy Adler, Karen A Chachu, et al.
Inflammatory Bowel Diseases|October 22, 2020
Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel DiseasesKristin E Burke, Bharati Kochar, Jessica R Allegretti, et al.
Alimentary Pharmacology & Therapeutics|October 16, 2025
Overall and Comparative Risk of Shingles With Advanced Therapies in Patients With Inflammatory Bowel DiseasesDhruv Ahuja, Soo-Kyung Park, Kuan-Hung Yeh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 15, 2024
Prevalence and Prognosis of Mild Inflammatory Bowel Disease: A Population-based Cohort Study, 1997-2020Henrik Albaek Jacobsen, Anastasia Karachalia-Sandri, Anthony C Ebert, et al.
Pageof 60

Showing results (481-490 of 592) with videos related to

Sort By:
Pageof 60
Alimentary Pharmacology & Therapeutics|April 14, 2015
Diabetes and the risk of infections with immunomodulator therapy in inflammatory bowel diseasesA N Ananthakrishnan, A Cagan, T Cai, et al.
The American Journal of Gastroenterology|October 22, 2025
Comparative Safety of Advanced Therapies in Patients with Ulcerative Colitis: An Administrative Claims-based StudyDhruv Ahuja, Claudia Dziegielewski, Kuan-Hung Yeh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 25, 2016
Statin Use Is Associated With Reduced Risk of Colorectal Cancer in Patients With Inflammatory Bowel DiseasesAshwin N Ananthakrishnan, Andrew Cagan, Tianxi Cai, et al.
The American Journal of Gastroenterology|February 13, 2026
The bidirectional relationship between cognitive function and active inflammatory bowel diseaseBharati Kochar, Adam S Faye, Elizabeth Araka, et al.
Gastroenterology|May 12, 2020
Dietary Inflammatory Potential and Risk of Crohn's Disease and Ulcerative ColitisChun-Han Lo, Paul Lochhead, Hamed Khalili, et al.
Digestive Diseases and Sciences|November 1, 2016
Vedolizumab Therapy Is Associated with an Improvement in Sleep Quality and Mood in Inflammatory Bowel DiseasesBetsy W Stevens, Nynke Z Borren, Gabriella Velonias, et al.
Gastroenterology|November 19, 2023
AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Crohn's DiseaseAshwin N Ananthakrishnan, Jeremy Adler, Karen A Chachu, et al.
Inflammatory Bowel Diseases|October 22, 2020
Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel DiseasesKristin E Burke, Bharati Kochar, Jessica R Allegretti, et al.
Alimentary Pharmacology & Therapeutics|October 16, 2025
Overall and Comparative Risk of Shingles With Advanced Therapies in Patients With Inflammatory Bowel DiseasesDhruv Ahuja, Soo-Kyung Park, Kuan-Hung Yeh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 15, 2024
Prevalence and Prognosis of Mild Inflammatory Bowel Disease: A Population-based Cohort Study, 1997-2020Henrik Albaek Jacobsen, Anastasia Karachalia-Sandri, Anthony C Ebert, et al.
Pageof 60